[
    {
        "aeid": 1390,
        "assayComponentEndpointName": "LTEA_HepaRG_SLC22A6",
        "exportReady": 1,
        "internalReady": 1,
        "assayComponentEndpointDesc": "Data from the assay component LTEA_HepaRG_SLC22A6 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_SLC22A6, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is organic anion transporter.",
        "assayFunctionType": "reporter gene",
        "normalizedDataType": "log2_fold_induction",
        "burstAssay": 0,
        "keyPositiveControl": null,
        "signalDirection": "bidirectional",
        "intendedTargetType": "rna",
        "intendedTargetTypeSub": "mRNA",
        "intendedTargetFamily": "transporter",
        "intendedTargetFamilySub": "organic anion transporter",
        "cellViabilityAssay": 0,
        "dataUsability": 1,
        "acid": 957,
        "assayComponentName": "LTEA_HepaRG_SLC22A6",
        "assayComponentDesc": "LTEA_HepaRG_SLC22A6 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of NR mediated transport.",
        "assayComponentTargetDesc": "Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.",
        "parameterReadoutType": "single",
        "assayDesignType": "inducible reporter",
        "assayDesignTypeSub": "mRNA induction",
        "biologicalProcessTarget": "regulation of transcription factor activity",
        "detectionTechnologyType": "Fluorescence",
        "detectionTechnologyTypeSub": "Fluorescence intensity",
        "detectionTechnology": "Fluidigm qRT-PCR",
        "keyAssayReagentType": null,
        "keyAssayReagent": null,
        "technologicalTargetType": "rna",
        "technologicalTargetTypeSub": "mRNA",
        "aid": 371,
        "assayName": "LTEA_HepaRG",
        "assayDesc": "LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",
        "timepointHr": 48.0,
        "organismId": 9606,
        "organism": "human",
        "tissue": "liver",
        "cellFormat": "cell line",
        "cellFreeComponentSource": "",
        "cellShortName": "HepaRG",
        "cellGrowthMode": "adherent",
        "assayFootprint": "microplate: 96-well plate",
        "assayFormatType": "cell-based",
        "assayFormatTypeSub": "cell-based format",
        "contentReadoutType": "multiplexed",
        "dilutionSolvent": "DMSO",
        "dilutionSolventPercentMax": 0.5,
        "asid": 9,
        "assaySourceName": "LTEA",
        "assaySourceLongName": "LifeTech/Expression Analysis",
        "assaySourceDesc": "Life Technologies, acquired by Thermo Fisher, is a Contract Research Organization (CRO) that provides transcriptomics and expression screening.",
        "gene": {
            "geneId": 353,
            "geneName": "solute carrier family 22 (organic anion transporter), member 6",
            "description": null,
            "geneSymbol": "SLC22A6",
            "organismId": 1,
            "trackStatus": "live",
            "entrezGeneId": 9356,
            "officialSymbol": "SLC22A6",
            "officialFullName": "solute carrier family 22 (organic anion transporter), member 6",
            "uniprotAccessionNumber": "Q4U2R8"
        },
        "assayList": null,
        "citations": {
            "doi": "doi: 10.1038/s41540-020-00166-2",
            "url": "https://pubmed.ncbi.nlm.nih.gov/33504769/",
            "pmid": 33504769,
            "title": "High-throughput toxicogenomic screening of chemicals in the environment using metabolically competent hepatic cell cultures",
            "author": "Franzosa JA, Bonzo JA, Jack J, Baker NC, Kothiya P, Witek RP, Hurban P, Siferd S, Hester S, Shah I, Ferguson SS, Houck KA, Wambaugh JF",
            "citation": "Franzosa JA, Bonzo JA, Jack J, Baker NC, Kothiya P, Witek RP, Hurban P, Siferd S, Hester S, Shah I, Ferguson SS, Houck KA, Wambaugh JF. High-throughput toxicogenomic screening of chemicals in the environment using metabolically competent hepatic cell cultures. NPJ Syst Biol Appl. 2021 Jan 27;7(1):7. doi: 10.1038/s41540-020-00166-2. PMID: 33504769; PMCID: PMC7840683.",
            "otherId": "0",
            "citationId": 247,
            "otherSource": ""
        }
    },
    {
        "aeid": 1392,
        "assayComponentEndpointName": "LTEA_HepaRG_KLK3",
        "exportReady": 1,
        "internalReady": 1,
        "assayComponentEndpointDesc": "Data from the assay component LTEA_HepaRG_KLK3 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_KLK3, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is Cellular remodeling.",
        "assayFunctionType": "reporter gene",
        "normalizedDataType": "log2_fold_induction",
        "burstAssay": 0,
        "keyPositiveControl": null,
        "signalDirection": "bidirectional",
        "intendedTargetType": "rna",
        "intendedTargetTypeSub": "mRNA",
        "intendedTargetFamily": "protease",
        "intendedTargetFamilySub": "Cellular remodeling",
        "cellViabilityAssay": 0,
        "dataUsability": 1,
        "acid": 958,
        "assayComponentName": "LTEA_HepaRG_KLK3",
        "assayComponentDesc": "LTEA_HepaRG_KLK3 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cellular remodeling.",
        "assayComponentTargetDesc": "Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.",
        "parameterReadoutType": "single",
        "assayDesignType": "inducible reporter",
        "assayDesignTypeSub": "mRNA induction",
        "biologicalProcessTarget": "regulation of transcription factor activity",
        "detectionTechnologyType": "Fluorescence",
        "detectionTechnologyTypeSub": "Fluorescence intensity",
        "detectionTechnology": "Fluidigm qRT-PCR",
        "keyAssayReagentType": null,
        "keyAssayReagent": null,
        "technologicalTargetType": "rna",
        "technologicalTargetTypeSub": "mRNA",
        "aid": 371,
        "assayName": "LTEA_HepaRG",
        "assayDesc": "LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",
        "timepointHr": 48.0,
        "organismId": 9606,
        "organism": "human",
        "tissue": "liver",
        "cellFormat": "cell line",
        "cellFreeComponentSource": "",
        "cellShortName": "HepaRG",
        "cellGrowthMode": "adherent",
        "assayFootprint": "microplate: 96-well plate",
        "assayFormatType": "cell-based",
        "assayFormatTypeSub": "cell-based format",
        "contentReadoutType": "multiplexed",
        "dilutionSolvent": "DMSO",
        "dilutionSolventPercentMax": 0.5,
        "asid": 9,
        "assaySourceName": "LTEA",
        "assaySourceLongName": "LifeTech/Expression Analysis",
        "assaySourceDesc": "Life Technologies, acquired by Thermo Fisher, is a Contract Research Organization (CRO) that provides transcriptomics and expression screening.",
        "gene": {
            "geneId": 25,
            "geneName": "kallikrein-related peptidase 3",
            "description": null,
            "geneSymbol": "KLK3",
            "organismId": 1,
            "trackStatus": "live",
            "entrezGeneId": 354,
            "officialSymbol": "KLK3",
            "officialFullName": "kallikrein-related peptidase 3",
            "uniprotAccessionNumber": "P07288"
        },
        "assayList": null,
        "citations": {
            "doi": "doi: 10.1038/s41540-020-00166-2",
            "url": "https://pubmed.ncbi.nlm.nih.gov/33504769/",
            "pmid": 33504769,
            "title": "High-throughput toxicogenomic screening of chemicals in the environment using metabolically competent hepatic cell cultures",
            "author": "Franzosa JA, Bonzo JA, Jack J, Baker NC, Kothiya P, Witek RP, Hurban P, Siferd S, Hester S, Shah I, Ferguson SS, Houck KA, Wambaugh JF",
            "citation": "Franzosa JA, Bonzo JA, Jack J, Baker NC, Kothiya P, Witek RP, Hurban P, Siferd S, Hester S, Shah I, Ferguson SS, Houck KA, Wambaugh JF. High-throughput toxicogenomic screening of chemicals in the environment using metabolically competent hepatic cell cultures. NPJ Syst Biol Appl. 2021 Jan 27;7(1):7. doi: 10.1038/s41540-020-00166-2. PMID: 33504769; PMCID: PMC7840683.",
            "otherId": "0",
            "citationId": 247,
            "otherSource": ""
        }
    },
    {
        "aeid": 1394,
        "assayComponentEndpointName": "LTEA_HepaRG_SLC10A1",
        "exportReady": 1,
        "internalReady": 1,
        "assayComponentEndpointDesc": "Data from the assay component LTEA_HepaRG_SLC10A1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_SLC10A1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is sodium/bile acid cotransporter.",
        "assayFunctionType": "reporter gene",
        "normalizedDataType": "log2_fold_induction",
        "burstAssay": 0,
        "keyPositiveControl": null,
        "signalDirection": "bidirectional",
        "intendedTargetType": "rna",
        "intendedTargetTypeSub": "mRNA",
        "intendedTargetFamily": "transporter",
        "intendedTargetFamilySub": "sodium/bile acid cotransporter",
        "cellViabilityAssay": 0,
        "dataUsability": 1,
        "acid": 959,
        "assayComponentName": "LTEA_HepaRG_SLC10A1",
        "assayComponentDesc": "LTEA_HepaRG_SLC10A1 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of NR mediated transport.",
        "assayComponentTargetDesc": "Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.",
        "parameterReadoutType": "single",
        "assayDesignType": "inducible reporter",
        "assayDesignTypeSub": "mRNA induction",
        "biologicalProcessTarget": "regulation of transcription factor activity",
        "detectionTechnologyType": "Fluorescence",
        "detectionTechnologyTypeSub": "Fluorescence intensity",
        "detectionTechnology": "Fluidigm qRT-PCR",
        "keyAssayReagentType": null,
        "keyAssayReagent": null,
        "technologicalTargetType": "rna",
        "technologicalTargetTypeSub": "mRNA",
        "aid": 371,
        "assayName": "LTEA_HepaRG",
        "assayDesc": "LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",
        "timepointHr": 48.0,
        "organismId": 9606,
        "organism": "human",
        "tissue": "liver",
        "cellFormat": "cell line",
        "cellFreeComponentSource": "",
        "cellShortName": "HepaRG",
        "cellGrowthMode": "adherent",
        "assayFootprint": "microplate: 96-well plate",
        "assayFormatType": "cell-based",
        "assayFormatTypeSub": "cell-based format",
        "contentReadoutType": "multiplexed",
        "dilutionSolvent": "DMSO",
        "dilutionSolventPercentMax": 0.5,
        "asid": 9,
        "assaySourceName": "LTEA",
        "assaySourceLongName": "LifeTech/Expression Analysis",
        "assaySourceDesc": "Life Technologies, acquired by Thermo Fisher, is a Contract Research Organization (CRO) that provides transcriptomics and expression screening.",
        "gene": {
            "geneId": 299,
            "geneName": "solute carrier family 10 (sodium/bile acid cotransporter), member 1",
            "description": null,
            "geneSymbol": "SLC10A1",
            "organismId": 1,
            "trackStatus": "live",
            "entrezGeneId": 6554,
            "officialSymbol": "SLC10A1",
            "officialFullName": "solute carrier family 10 (sodium/bile acid cotransporter), member 1",
            "uniprotAccessionNumber": "Q14973"
        },
        "assayList": null,
        "citations": {
            "doi": "doi: 10.1038/s41540-020-00166-2",
            "url": "https://pubmed.ncbi.nlm.nih.gov/33504769/",
            "pmid": 33504769,
            "title": "High-throughput toxicogenomic screening of chemicals in the environment using metabolically competent hepatic cell cultures",
            "author": "Franzosa JA, Bonzo JA, Jack J, Baker NC, Kothiya P, Witek RP, Hurban P, Siferd S, Hester S, Shah I, Ferguson SS, Houck KA, Wambaugh JF",
            "citation": "Franzosa JA, Bonzo JA, Jack J, Baker NC, Kothiya P, Witek RP, Hurban P, Siferd S, Hester S, Shah I, Ferguson SS, Houck KA, Wambaugh JF. High-throughput toxicogenomic screening of chemicals in the environment using metabolically competent hepatic cell cultures. NPJ Syst Biol Appl. 2021 Jan 27;7(1):7. doi: 10.1038/s41540-020-00166-2. PMID: 33504769; PMCID: PMC7840683.",
            "otherId": "0",
            "citationId": 247,
            "otherSource": ""
        }
    }
]